Welcome to MyStrategist, an online experience like no other in the medical device industry.

MedTech Strategist Market Pathways explores the people, challenges, and opportunities impacting the medtech regulatory and reimbursement community. Explore our coverage. Think Strategically. Subscribe Today.

Subscribe Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Business Strategies

Caption Health: Transforming Cardiac Imaging with AI

In keeping with its proactive stance on establishing a regulatory framework for the upcoming wave of AI-based software technologies, the FDA in February granted de novo authorization for the first AI-based product for acquiring cardiac ultrasound images. Deployment has begun in high-need acute point-of-care settings, including those treating COVID-19 patients.

Subscribe now to read the full analysis

Registration is now open for the 7th annual Innovation Summit Dublin, September 7-9, 2020. The industry's most anticipated event will sell out. Register Today.

Register   Learn More

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Perspective & Commentary

COVID-19 Crisis: Accelerating Transformation in Medical Device Research

Rachael Fleurence, the former executive director of NEST, heads up a consultancy focused on real-world evidence and innovative medtech research strategies. She offers her perspective on opportunities that are likely to arise out of the COVID-19 crisis to keep generating high-quality evidence while traditional studies are disrupted. These include significant changes to clinical trial protocol, including remote monitoring of participants, for which FDA has just issued guidance.

Subscribe now to read the full analysis

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More
More From Market Pathways:

As the Regulatory World Turns: Q&A with MDMA’s Mark Leahey, Part 2

In the second part of our interview, Mark Leahey addresses the changes taking place in the European regulatory regimen and how that is affecting US companies. He also talks about how the US political situation will impact medtech, and the ongoing public debate on balancing safety and innovation in the device industry.

Read Article